Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Targu Mures – page 7

122 clinical trials in Targu Mures, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Targu Mures at a glance
122
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

122 trials in Targu Mures

Open in trial search

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Chronic kidney disease+1

Not recruiting

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Crohn's disease

Not recruiting

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Study comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Endometriosis

Not recruiting

A study testing vipoglanstat for women with moderate to severe endometriosis-related pain

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:GS-248
  • Sponsor:Gesynta Pharma AB

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting

Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Embonate
  • Sponsor:Novo Nordisk A/S

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Targu Mures

What the registry says about research in the country

01 Cardiovascular & Blood Disorders

Clinical research focusing on cardiovascular conditions and blood disorders, including groundbreaking trials for hypertension management and rare blood conditions.

  • Pulmonary Arterial Hypertension therapies
  • Atrial Fibrillation treatments
  • Paroxysmal Nocturnal Hemoglobinuria studies

Novel treatments being evaluated to improve patient outcomes in resistant hypertension and blood disorders.

02 Oncology & Hematology

Innovative research in blood cancers and lymphomas, exploring new therapeutic approaches for various forms of leukemia and lymphoma.

  • Chronic Myeloid Leukemia treatments
  • Large B-cell Lymphoma therapies
  • Prostate Cancer interventions

Evaluating combination therapies and targeted treatments for better cancer care outcomes.

03 Chronic Conditions

Research focused on managing chronic diseases, including innovative approaches to kidney disease, diabetes, and respiratory conditions.

  • Type 2 Diabetes management
  • Chronic Kidney Disease treatments
  • COPD therapeutic solutions

Studies aim to improve quality of life and disease management for patients with chronic conditions.

04 Neurological Disorders

Advanced research in neurological conditions, investigating new treatments for epilepsy and multiple sclerosis.

  • Multiple Sclerosis therapies
  • Epilepsy treatment optimization
  • Myasthenia Gravis management

Evaluating innovative therapeutic approaches for better neurological disease control.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.